Your browser doesn't support javascript.
loading
Naltrexone ameliorates functional network abnormalities in alcohol-dependent individuals.
Morris, Laurel S; Baek, Kwangyeol; Tait, Roger; Elliott, Rebecca; Ersche, Karen D; Flechais, Remy; McGonigle, John; Murphy, Anna; Nestor, Liam J; Orban, Csaba; Passetti, Filippo; Paterson, Louise M; Rabiner, Ilan; Reed, Laurence; Smith, Dana; Suckling, John; Taylor, Eleanor M; Bullmore, Edward T; Lingford-Hughes, Anne R; Deakin, Bill; Nutt, David J; Sahakian, Barbara J; Robbins, Trevor W; Voon, Valerie.
Afiliación
  • Morris LS; Department of Psychology, University of Cambridge, UK.
  • Baek K; Behavioural and Clinical Neuroscience Institute, University of Cambridge, UK.
  • Tait R; Department of Psychiatry, University of Cambridge, UK.
  • Elliott R; Behavioural and Clinical Neuroscience Institute, University of Cambridge, UK.
  • Ersche KD; Department of Psychiatry, University of Cambridge, UK.
  • Flechais R; Neuroscience and Psychiatry Unit, University of Manchester, UK.
  • McGonigle J; Behavioural and Clinical Neuroscience Institute, University of Cambridge, UK.
  • Murphy A; Department of Psychiatry, University of Cambridge, UK.
  • Nestor LJ; Centre for Neuropsychopharmacology, Division of Brain Sciences, Imperial College London, UK.
  • Orban C; Centre for Neuropsychopharmacology, Division of Brain Sciences, Imperial College London, UK.
  • Passetti F; Neuroscience and Psychiatry Unit, University of Manchester, UK.
  • Paterson LM; Behavioural and Clinical Neuroscience Institute, University of Cambridge, UK.
  • Rabiner I; Department of Psychiatry, University of Cambridge, UK.
  • Reed L; Centre for Neuropsychopharmacology, Division of Brain Sciences, Imperial College London, UK.
  • Smith D; Centre for Neuropsychopharmacology, Division of Brain Sciences, Imperial College London, UK.
  • Suckling J; Behavioural and Clinical Neuroscience Institute, University of Cambridge, UK.
  • Taylor EM; Department of Psychiatry, University of Cambridge, UK.
  • Bullmore ET; Centre for Neuropsychopharmacology, Division of Brain Sciences, Imperial College London, UK.
  • Lingford-Hughes AR; Centre for Neuropsychopharmacology, Division of Brain Sciences, Imperial College London, UK.
  • Deakin B; Imanova, Centre for Imaging Sciences, UK.
  • Nutt DJ; Centre for Neuropsychopharmacology, Division of Brain Sciences, Imperial College London, UK.
  • Sahakian BJ; Department of Psychology, University of Cambridge, UK.
  • Robbins TW; Behavioural and Clinical Neuroscience Institute, University of Cambridge, UK.
  • Voon V; Department of Psychiatry, University of Cambridge, UK.
Addict Biol ; 23(1): 425-436, 2018 01.
Article en En | MEDLINE | ID: mdl-28247526
ABSTRACT
Naltrexone, an opioid receptor antagonist, is commonly used as a relapse prevention medication in alcohol and opiate addiction, but its efficacy and the mechanisms underpinning its clinical usefulness are not well characterized. In the current study, we examined the effects of 50-mg naltrexone compared with placebo on neural network changes associated with substance dependence in 21 alcohol and 36 poly-drug-dependent individuals compared with 36 healthy volunteers. Graph theoretic and network-based statistical analysis of resting-state functional magnetic resonance imaging (MRI) data revealed that alcohol-dependent subjects had reduced functional connectivity of a dispersed network compared with both poly-drug-dependent and healthy subjects. Higher local efficiency was observed in both patient groups, indicating clustered and segregated network topology and information processing. Naltrexone normalized heightened local efficiency of the neural network in alcohol-dependent individuals, to the same levels as healthy volunteers. Naltrexone failed to have an effect on the local efficiency in abstinent poly-substance-dependent individuals. Across groups, local efficiency was associated with substance, but no alcohol exposure implicating local efficiency as a potential premorbid risk factor in alcohol use disorders that can be ameliorated by naltrexone. These findings suggest one possible mechanism for the clinical effects of naltrexone, namely, the amelioration of disrupted network topology.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Encéfalo / Disuasivos de Alcohol / Alcoholismo / Naltrexona Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Addict Biol Asunto de la revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Encéfalo / Disuasivos de Alcohol / Alcoholismo / Naltrexona Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Addict Biol Asunto de la revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido